The ADCA toolkit is quite extensive and is intended to serve as a public health guide throughout the process of developing agreements with pharmacies. To this end, it provides numerous documents and guidelines for recording the steps taken to develop a CDTA or Memorandum of Understanding that defines the role of pharmacies in the event of a disaster. The toolkit also calls on local health authorities to develop strategies with pharmacists that clearly define how medicines and vaccines are dispensed in an emergency. Specific instruments include: A collaborative practice agreement can be called a consultation agreement, a doctor-pharmacist agreement, a standing order or a physician protocol or delegation. CDTM is an extension of the traditional pharmacist space that enables pharmacist-led management of medication-related issues (PRD) with a focus on a collaborative and interdisciplinary approach to healthcare pharmacy practice. The conditions for a CPA are set by the cooperating pharmacist and physician, although templates exist online. CPAs may be specific to a patient population of mutual interest, a particular clinical situation or disease, and/or may describe an evidence-based protocol for the management of patient regimens under CPA. CPAs are the subject of intense debate in pharmacy and in the medical professions. That our WADA develop model national legislation to address the expansion of the pharmacist sector, which is inappropriate or constitutes the practice of medicine, including, but not limited to, the issue of the interpretation or use of independent practice agreements without adequate medical supervision and cooperation with interested States and disciplines to advance such legislation (Action Directive).  Since 2010, Medicare Part B has not provided reimbursement for pharmacists.  The Pharmacy and Medically Underserved Areas Enhancement Act (H.R.
592/p. 109) was introduced in January 2017 in the House of Representatives and The Senate.   This would allow pharmacists to obtain reimbursement through Medicare Part B for the provision of health services in medically underserved communities defined by the state.  These must be services for which pharmacists are licensed in their respective states and services for which physicians would have been compensated under Medicare.  State pharmacist associations have a rich history of leadership in revolutionary advocacy efforts both to advance pharmacy practice in all practice settings and for considerable leadership in the fight to promote market justice for patients, taxpayers and pharmacists in the community. .